Get the full picture
Sign in to uncover key details.
SignPath Pharma
Business Services · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7984 S 1300 E, Sandy, Utah, 84094, Unite...Phone Number
(215) 538-9996Website
www.signpathpharma.comRevenue
<$5 MillionIndustry
About SignPath Pharma
Signpath Pharma is a clinical-stage company based in Sandy, Utah, specializing in the development of heart-safe drugs through its unique CorreQT platform. The company focuses on mitigating cardiac side effects associated with various medications, particularly in the context of cancer treatment. Their lead product, LipoCurc, is a proprietary liposomal formulation of curcumin that has shown efficacy in clinical trials without cardiac toxicity. Signpath aims to address significant unmet medical needs by creating innovative treatments for patients, particularly those with cancer and other conditions requiring safer drug alternatives.Explore more
SignPath Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to SignPath Pharma
Compare insights from companies similar to SignPath Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SignPath Pharma Tech Stack
A closer look at the technologies used by SignPath Pharma
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding SignPath Pharma
Sign Up For FreeTo access detailed company insights
Signpath Pharma is a clinical-stage company based in Sandy, Utah, specializing in the development of heart-safe drugs through its unique CorreQT platform. The company focuses on mitigating cardiac side effects associated with various medications, particularly in the context of cancer treatment. Their lead product, LipoCurc, is a proprietary liposom... Read More
